The largest database of trusted experimental protocols

118 protocols using ab18197

1

Immunohistochemical Analysis of Cell Proliferation in Atheromatous Aortic Valve Lesions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell proliferation in atheromatous lesions from aortic valves was assessed using anti‐proliferating cell nuclear antigen (PCNA) antibody (rabbit polyclonal) (ab18197, Abcam). For double immunohistochemical staining, the sections were autoclaved in citrate buffer to restore antigenicity. A monoclonal anti‐macrophage MAC3 antibody (550292; BD Pharmingen, San Diego, CA) and polyclonal anti‐PCNA form antibodies (ab18197, anti‐PCNA antibody [rabbit polyclonal]; Abcam) were used as primary antibodies. Normal rabbit IgG (sc‐2027, Santa Cruz) was used for MAC3 antibody negative control. Goat anti‐rabbit IgG (H+L) (highly cross‐adsorbed; Alexa Fluor 488, A11034; Thermo Fisher Scientific Inc.) was used as a secondary antibody for anti‐PCNA. Normal rabbit IgG (sc‐2027, Santa Cruz) was used as the PCNA antibody‐negative control. Goat anti‐rat IgG (H+L) (Alexa Fluor 555, A21434; Thermo Fisher Scientific Inc.) was used as a secondary antibody for anti‐PCNA.
+ Open protocol
+ Expand
2

TRIM16 Protein Quantification via Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protein level of TRIM16 was detected using Western blot, according to the experimental procedures recorded in the previous publications [29 (link)]. Briefly, transfected cells were lysed in Radioimmunoprecipitation assay (RIPA) lysis buffer with protease inhibitor (Thermo Fisher Scientific) to extract total protein. The protein quantification was measured by the BCATM Protein Assay Kit (Pierce, Appleton, WI, USA). Then the equivalent protein (50 µg) was added to the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to obtain the target protein. Next, the target proteins in the gel were transferred onto polyvinylidene difluoride (PVDF) membranes and incubated with primary antibodies against TRIM16 (ab72129, 1:2000, Abcam, Cambridge, MA, USA), hexokinase 2 (HK2, ab227198, 1:5000, Abcam), B-cell lymphoma protein 2 (Bcl-2)-associated X (BAX, ab32503, 1:2000, Abcam), Matrix metalloproteinase 2 (MMP2, ab92536, 1:1000, Abcam), Proliferating cell nuclear antigen (PCNA, ab18197, 1:1000, Abcam), and β-actin at 4°C overnight. The membranes were then incubated with second antibodies (Horseradish peroxidase-conjugated IgG antibody). Finally, the Western blot intensities were detected using LAS 4000 Image Reader (Fujifilm, Tokyo, Japan)
+ Open protocol
+ Expand
3

Western Blot Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein expressions were determined using Western blot assay [33 (link)]. Total protein was extracted using RIPA cell lysate buffer containing a protease inhibitor cocktail. The protein concentration was then measured using the BCA method. The proteins were separated by SDS-PAGE gel electrophoresis and transferred to PVDF membranes. The membranes were then blocked with 5% BSA at room temperature for 50 min to eliminate nonspecific binding of primary and secondary antibodies. Primary antibody (cleaved-Caspase3 antibody, ab32042, 1:1000, Abcam; GAPDH antibody, ab9485, 1:1000, Abcam; PCNA antibody, ab18197, 1:1000, Abcam; CCND2 antibody, ab207604, 1:1000, Abcam;) was then added to the PVDF membrane and incubated overnight at 4°C. The next day, the membranes were probed with the corresponding HRP-labeled secondary antibody (ab7090, 1:1000, Abcam) by incubation at room temperature for 2 h. ECL chromogenic solution A and B were mixed, added dropwise to the position of the target band on the membrane, and photographed using ImageJ software.
+ Open protocol
+ Expand
4

Western Blot Analysis of Cell Adhesion and Proliferation Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The radioimmunoprecipitation assay buffer (Thermo Fisher Scientific) was used to isolate the total protein. Following quantification with bicinchoninic acid kit (Thermo Fisher Scientific), 20 μg samples were separated via sodium dodecyl sulfate–polyacrylamide gel electrophoresis and transferred on the polyvinylidene fluoride membrane (Bio-Rad, Hercules, CA, USA). The membranes were blocked in 5% fat-free milk for 1 h and then incubated with primary antibodies (E-cadherin [ab40772, 1:8000; Abcam, Cambridge, UK], intercellular adhesion molecule-1 [ICAM-1] [ab109361, 1:1000; Abcam], vitronectin [ab45139, 1:2000; Abcam], proliferating cell nuclear antigen [PCNA] [ab18197, 1:5000; Abcam], matrix metalloproteinase 9 [MMP9] [ab76003, 1:5000; Abcam], AQP4 [ab81355, 1:300; Abcam], and GAPDH [1:5000; Abcam]) overnight, followed by interacting with secondary antibodies (ab6721, 1:2000; Abcam) for 2 h. Then blots were exposed to enhanced chemiluminescence (Solarbio) and detected via ImageJ v1.8, with GAPDH as a normalized control.
+ Open protocol
+ Expand
5

Quantifying Ectopic DEK Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
U2-OS shDEK cells were transfected with plasmids encoding DEK WT-GFP or DEK PBD2-Mut2-GFP. After 24 h, cells were sorted using a FACSAria Illu (BD Biosciences). Low DEK GFP expressing cells were collected in McCoy’s 5a modified medium supplemented with 20% FCS. To determine expression levels of endogenous and ectopic DEK, total proteins were extracted with SDS lysis buffer. Cleared lysates were subjected to Western blotting with the following antibodies: polyclonal rabbit α-DEK K-877 (1:20,000; [21 (link)]), polyclonal rabbit α-PCNA (1:5,000; ab18197, Abcam).
+ Open protocol
+ Expand
6

Protein Quantification and Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total proteins were extracted using RIPA Lysis Buffer (Beyotime) and next separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The separated proteins were transferred onto polyvinylidene difluoride (PVDF) membranes (Bio-Rad) and incubated with the blocking buffer. Subsequently, the membranes containing protein bands were probed with the primary antibodies against Ki67 (ab231172; Abcam, Cambridge, MA, USA), Proliferating cell nuclear antigen (PCNA; ab18197; Abcam), CSF-1 (ab99178; Abcam) and GAPDH (ab9485; Abcam) at 4 °C overnight and subsequently treated with the secondary antibodies (ab205718; Abcam). The protein bands were imaged using an enhanced chemiluminescence kit (ECL; Beyotime). Each sample was in triplicate, and three independent experiments were conducted.
+ Open protocol
+ Expand
7

Comprehensive Antibody-based Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rb anti-survivin (#2808), −EGF (ab9695), −EGFR (ab23430), −p-ErbB2 (ab131104), −ErbB3 (ab20161), −FOXO3a (ab47409), −FOXO1 (ab39670), and -p-FOXO (T32, ab26649), or m anti-p-EGFR (Y1173; ab24912), −H2B (ab52484) and -PCNA (ab18197) were from Abcam (Cambridge, MA, USA). Rb anti-ErbB2 (#2165), −Cyclin D1 (#2978), −PTEN (#9188), −AKT (#2938), −p-AKT (S463, #4060), −ERK (#4695), −p-ERK (T202/Y204, #4370), −JNK (#9258), −p-JNK (T183/Y185, #9255), −p38 (#8690), −p-p38 (T180/Y182, #2387), −Bcl2 (#2870), −Bcl-xL (#2762) and -Skp2 (#4358) were from Cell Signaling Technology (Danvers, MA, USA). The m anti-NRG1 (MAB377) was from R&D Systems (Minneapolis, MN, USA). The m anti-nuclear factor kappa B (NF-κB)/p65 (IMG-150A) was from Imgenex (San Diego, CA, USA), the Rb anti-MDM2 (s1357) was from Epitomics (Burlingame, CA, USA) and the m anti-actin (cp01) was from Calbiochem (San Diego, CA, USA). Mouse monoclonal anti-human anti-BRCA1-IRIS was developed in our laboratory.
+ Open protocol
+ Expand
8

Immunohistochemical Analysis of Tumor Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors or mice tissue specimens were excised after sacrificing mice and specimens were immediately fixed in 10% neutral buffered formaldehyde for 24 h, progressively dehydrated in solutions containing an increasing percentage of ethanol (75, 85, 95 and 100%, v/v), and embedded into paraffin blocks. Sections were cut from the paraffin blocks and IHC was carried out using anti–Ki-67 (1:250; Catalog #ab15580, Abcam), anti-PCNA (1:250; Catalog #ab18197, Abcam) and anti-BMI-1 (1250; Catalog #ab14389, Abcam) as primary antibodies. For hematoxylin-eosin (H&E) staining, samples were stained with H&E to indicate nucleus and cytoplasm, respectively.
+ Open protocol
+ Expand
9

Protosappanin B Anti-Cancer Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protosappanin B was purchased from Shanghai Yuanye Bio-Technology Co. Ltd. (B21622-20 mg, Shanghai, China). Reagents, signaling pathway agonists and antibodies were purchased from the following companies: RPMI-1640 medium, DMEM medium (Shanghai Yuanye Bio-technology, Shanghai, China); Streptavidin Peroxidase immunohistochemistry kit (GS4961, GS4962), cell counting kit-8 (QN1293), Annexin V-FITC/PI double staining apoptosis detection kit (SNM530), and ECL western blotting detection kit (QN1155) (Beijing BioRab Technology Co. Ltd., Beijing, China); BCA protein assay kit (C05-02001), western blocking buffer (5% BSA, C05-06002) (Beijing Biosynthesis Biotechnology Co., Ltd, Beijing, China); IGF-1 (K002504P), AZD2858 (A126819), and TPA (bs-1545R) (Shanghai Hengfei Biotechnology Co. Ltd. Shanghai, China); Anti-GOLPH3 (ab98023), Anti-p-AKT (ab8805), Anti-AKT (ab38449), and anti-PCNA (proliferating cell nuclear antigen) (ab18197) (Abcam, Cambridge, UK); Anti-p-p70S6K (ribosomal protein S6 kinase, 70 kDa) (sc-8416), Anti-p70S6K (sc-8418), Anti-β-catenin (sc-7963), Anti-p-ERK1/2(extracellular signal-regulated kinase 1 and 2) (sc-81492), Anti-ERK1/2 (sc-514302), Anti-GAPDH (sc-365062), and secondary antibodies (sc-516102, sc-2357) (Santa Cruz Biotechnology, Inc., Dallas, TX, USA).
+ Open protocol
+ Expand
10

Antibodies for Cellular Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibodies used in this study were: rabbit anti-KIF23 antibody (Abcam, ab235955; 1:200 dilution for immunohistochemistry and 1:1000 dilution for western blotting), rabbit anti-β-actin antibody (1:1000 dilution for western blotting; ab8227, Abcam plc., Cambridge, UK), rabbit anti-Ki67 antibody (1:200 dilution for immunohistochemistry and 1:1000 dilution for western blotting; ab16667, Abcam), rabbit anti-proliferating cell nuclear antigen (PCNA) antibody (1:500 dilution for western blotting; ab18197, Abcam), and rabbit anti-Borealin/CDCA8 (ab70910, Abcam; 1:50 dilution for immunohistochemistry).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!